Connor, Clark & Lunn Investment Management Ltd. Acadia Pharmaceuticals Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 685,716 shares of ACAD stock, worth $11.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

685,716

Previous 972,665 29.5%

Holding current value

$11.8 Million

Previous $15 Million 15.95%

% of portfolio

0.06%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$14.29 - $18.76 $4.1 Million - $5.38 Million	-286,949 Reduced 29.5%	685,716 $12.6 Million
Q3 2024 Nov 08, 2024	SELL	$15.14 - $19.14 $4.25 Million - $5.38 Million	-280,877 Reduced 22.41%	972,665 $15 Million
Q2 2024 Aug 09, 2024	BUY	$14.62 - $18.42 $5.81 Million - $7.32 Million	397,243 Added 46.39%	1,253,542 $20.4 Million
Q1 2024 May 09, 2024	BUY	$17.79 - $30.86 $4.07 Million - $7.06 Million	228,915 Added 36.49%	856,299 $15.8 Million
Q4 2023 Feb 09, 2024	SELL	$20.78 - $31.77 $126,446 - $193,320	-6,085 Reduced 0.96%	627,384 $19.6 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $2.04 Million - $3.28 Million	97,888 Added 18.28%	633,469 $13.2 Million
Q2 2023 Aug 10, 2023	BUY	$17.8 - $25.65 $665,773 - $959,386	37,403 Added 7.51%	535,581 $12.8 Million
Q1 2023 May 09, 2023	BUY	$16.32 - $20.92 $140,874 - $180,581	8,632 Added 1.76%	498,178 $9.38 Million
Q4 2022 Feb 10, 2023	SELL	$14.2 - $18.63 $289,325 - $379,586	-20,375 Reduced 4.0%	489,546 $7.79 Million
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $5.06 Million - $6.55 Million	358,405 Added 236.55%	509,921 $8.34 Million
Q2 2022 Aug 05, 2022	BUY	$13.01 - $27.22 $1.22 Million - $2.56 Million	93,881 Added 162.89%	151,516 $2.14 Million
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $1.21 Million - $1.58 Million	57,635 New	57,635 $1.4 Million
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $1.46 Million - $2.45 Million	-112,325 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$15.07 - $22.34 $1.69 Million - $2.51 Million	112,325 New	112,325 $1.72 Million

Others Institutions Holding ACAD

# of Institutions

315

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Acadia Pharmaceuticals Inc Transaction History